Ono Pharmaceutical Co Ltd
XMUN:ON4
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
Ono Pharmaceutical Co Ltd
XMUN:ON4
|
JP |
|
M
|
Main Street Capital Corp
SWB:13M
|
US |
|
J
|
Jiangxi Copper Co Ltd
HKEX:358
|
CN |
|
N
|
NTT Data Corp
OTC:NTTDF
|
JP |
|
D
|
Dow Inc
F:2OY
|
US |
|
B
|
Bank of Nova Scotia
XBER:BKN
|
CA |
|
L
|
Lockheed Martin Corp
DUS:LOM
|
US |
|
A
|
Altria Group Inc
XHAM:PHM7
|
US |
Ono Pharmaceutical Co Ltd
Ono Pharmaceutical is a Japanese drugmaker that discovers, develops, manufactures, and sells prescription medicines. Its business is centered on treating serious diseases, with a strong focus on cancer and other specialty areas where patients often need long-term, physician-led treatment rather than everyday consumer drugs. The company sells mainly to hospitals, clinics, and pharmacies through the healthcare system, not directly to patients. It makes money by earning sales from patented and branded medicines, and by licensing some of its drug technology or products to other pharmaceutical companies when a partner can help develop or distribute them in different markets. What sets Ono apart is its role as a specialist research-based pharmaceutical company. Instead of competing as a broad consumer health brand, it concentrates on creating drugs that doctors prescribe for complex conditions, especially in areas where strong clinical evidence and regulatory approval matter more than scale or retail presence.
Ono Pharmaceutical is a Japanese drugmaker that discovers, develops, manufactures, and sells prescription medicines. Its business is centered on treating serious diseases, with a strong focus on cancer and other specialty areas where patients often need long-term, physician-led treatment rather than everyday consumer drugs.
The company sells mainly to hospitals, clinics, and pharmacies through the healthcare system, not directly to patients. It makes money by earning sales from patented and branded medicines, and by licensing some of its drug technology or products to other pharmaceutical companies when a partner can help develop or distribute them in different markets.
What sets Ono apart is its role as a specialist research-based pharmaceutical company. Instead of competing as a broad consumer health brand, it concentrates on creating drugs that doctors prescribe for complex conditions, especially in areas where strong clinical evidence and regulatory approval matter more than scale or retail presence.
